# Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma

> **NCT00327613** · — · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 60 (actual)

## Conditions studied

- Pseudoexfoliation Syndrome
- Glaucoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00327613
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2008-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327613, "Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00327613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*